Company Intelligence
Ceribell
Ceribell provides enterprise-grade artificial intelligence solutions, delivering specialized Ceribell Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Sunnyvale, United States
- Website
- www.ceribell.com
- Founded
- 2014
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Ceribell is a Healthcare AI company based in Sunnyvale, United States, founded in 2014.
Sunnyvale AI-powered point-of-care EEG platform for rapid non-convulsive seizure detection in acute care.
Verified founder profiles on Brel: Jane Chao PhD, Jane Chao.
What it builds
Ceribell Platform
Why It Matters
Ceribell provides enterprise-grade artificial intelligence solutions, delivering specialized Ceribell Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Ceribell System
Explore Ceribell System by Ceribell. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Ceribell
Industry
Industries served
- Medical Devices
Products
Capabilities
Ceribell's AI analyzes EEG signals from its portable headband to detect patterns associated with non-convulsive seizures and status epilepticus faster than conventional…
Features
- Ceribell System portable point-of-care EEG headband with AI algorithms including Clarity for electrographic status epilep
- Clarity for electrographic status epilepticus detection
- enabling rapid EEG acquisition in ICU
- emergency settings without conventional EEG setup delays
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
- July 22, 2024: Ceribell announced publication of multi-center study showing shorter ICU stays with point-of-care EEG versus conventional EEG. Latest
- Company founded 2014 · founded Source
- Leadership 2014 · leadership Source
- Development 2023 · development Source
- July 22, 2024: Ceribell announced publication of multi-center study showing shorter ICU stays with point-of-care EEG versus conventional EEG. Research
- July 22, 2024: Neurocritical Care publication on ICU length-of-stay and functional outcomes versus conventional EEG. Research
- Sources and references Research
- Ceribell ICU outcomes press release (July 22, 2024) and leadership team page.Ceribell — ICU study publication (ceribell.com, July 22, 2024)Ceribell — Leadership team (ceribell.com)Reviewed July 10, 2026. Research
Frequently Asked Questions
What does Ceribell do?
Ceribell specializes in artificial intelligence, developing Ceribell Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Ceribell based and when was it founded?
Ceribell is based in United States and was founded in 2014.
What are the main products offered by Ceribell?
The flagship platform from Ceribell is Ceribell Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Ceribell?
Ceribell primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.